v3.25.2
Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Isabella Bank Corporation Restricted Stock Plan
Common Stock
Common Stock
Isabella Bank Corporation Restricted Stock Plan
Additional Paid-in Capital
Isabella Bank Corporation Restricted Stock Plan
Shares to be Issued for Deferred Compensation Obligations
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balances at Dec. 31, 2023 $ 202,402   $ 127,323     $ 3,693 $ 97,282 $ (25,896)
Beginning balances, shares at Dec. 31, 2023     7,485,889          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Comprehensive income (loss) 4,872           6,612 (1,740)
Issuance of common stock 840 $ 0 $ 840          
Issuance of common stock, shares     43,980          
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period       16,240        
Common stock transferred from the Rabbi Trust to satisfy deferred compensation obligations 0   $ (21)     21    
Share based payment awards under equity compensation plan 279         279    
APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition   45     $ 45      
Common stock purchased for deferred compensation obligations (701)   (701)          
Common stock repurchased pursuant to publicly announced repurchase plan (1,402)   $ (1,402)          
Common stock repurchased pursuant to publicly announced repurchase plan, shares     (72,093)          
Cash dividends (4,086)           (4,086)  
Ending balances at Jun. 30, 2024 202,249   $ 126,126     3,951 99,808 (27,636)
Ending balances, shares at Jun. 30, 2024     7,474,016          
Beginning balances at Mar. 31, 2024 200,674   $ 126,656     3,890 98,318 (28,190)
Beginning balances, shares at Mar. 31, 2024     7,488,101          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Comprehensive income (loss) 4,035           3,481 554
Issuance of common stock 393   $ 393          
Issuance of common stock, shares     21,524          
Share based payment awards under equity compensation plan 61         61    
APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition   20     20      
Common stock purchased for deferred compensation obligations (281)   $ (281)          
Common stock repurchased pursuant to publicly announced repurchase plan (662)   $ (662)          
Common stock repurchased pursuant to publicly announced repurchase plan, shares     (35,609)          
Cash dividends (1,991)           (1,991)  
Ending balances at Jun. 30, 2024 202,249   $ 126,126     3,951 99,808 (27,636)
Ending balances, shares at Jun. 30, 2024     7,474,016          
Beginning balances at Dec. 31, 2024 $ 210,276   $ 126,224     2,383 103,024 (21,355)
Beginning balances, shares at Dec. 31, 2024 7,424,893   7,424,893          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Comprehensive income (loss) $ 15,948           8,980 6,968
Issuance of common stock 759 0 $ 759          
Issuance of common stock, shares     28,830          
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period       11,367        
Common stock transferred from the Rabbi Trust to satisfy deferred compensation obligations 0   $ (253)     253    
Share based payment awards under equity compensation plan 201         201    
APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition   21     21      
Common stock repurchased pursuant to publicly announced repurchase plan (2,650)   $ (2,650)          
Common stock repurchased pursuant to publicly announced repurchase plan, shares     (103,406)          
Cash dividends (4,055)           (4,055)  
Ending balances at Jun. 30, 2025 $ 220,500   $ 124,607     2,331 107,949 (14,387)
Ending balances, shares at Jun. 30, 2025 7,361,684   7,361,684          
Beginning balances at Mar. 31, 2025 $ 215,556   $ 125,547     2,508 104,940 (17,439)
Beginning balances, shares at Mar. 31, 2025     7,408,010          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Comprehensive income (loss) 8,083           5,031 3,052
Issuance of common stock 340   $ 340          
Issuance of common stock, shares     11,498          
Common stock transferred from the Rabbi Trust to satisfy deferred compensation obligations 0   $ (211)     211    
Share based payment awards under equity compensation plan 34         34    
APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition   $ 14     $ 14      
Common stock repurchased pursuant to publicly announced repurchase plan (1,505)   $ (1,505)          
Common stock repurchased pursuant to publicly announced repurchase plan, shares     (57,824)          
Cash dividends (2,022)           (2,022)  
Ending balances at Jun. 30, 2025 $ 220,500   $ 124,607     $ 2,331 $ 107,949 $ (14,387)
Ending balances, shares at Jun. 30, 2025 7,361,684   7,361,684